NCT01629875

Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line

Efficacy and Safety of DWP450 Compared With Botox in Patients With Moderate to Severe Glabellar Line: Active Controlled, Double-blind, Randomized, Multi-center, Phase I/III Clinical Trial

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 268 (estimated)
• Sponsor: Daewoong Pharmaceutical Co. LTD. · Industry
• Sex: All
• Age: 20 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study was to observe Efficacy and safety of DWP450 compared with Botox in moderate to severe glabellar line patients.

Conditions

• Moderate to Severe Glabellar Line

Interventions

Type	Name	Description
DRUG	Generic equivalent of Clostridium Botulinum A Toxin
DRUG	Botox (Clostridium Botulinum A Toxin)

Timeline

• Start date: 2012-03-01
• Primary completion: 2012-08-01
• Completion: 2012-11-01
• First posted: 2012-06-28
• Last updated: 2012-11-07

Locations

1 site across 1 country: South Korea